Back to all studies
Active Not RecruitingNCT06539780

Imagery Rescripting as a Treatment for Early Psychosis

This active not recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOtherFrom 16 Years to 45 Years
In plain English

Key information made simple

This study is looking at test the effect of imagery rescripting (ImRs) in early psychosis for people with Psychosis, Schizophrenia, or Psychoses, Traumatic. Participants take part in the program and complete follow-up questionnaires or assessments. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Need help deciding?

Ask HopeStage to review this study with me

This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.

Loading the security check...
Study reference: NCT06539780. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.
In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com